Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension

Published:2022-05-01 Issue:9 Volume:205 Page:1102-1111
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Rhodes Christopher J.¹^ORCID,Wharton John¹^ORCID,Swietlik Emilia M.²,Harbaum Lars¹^ORCID,Girerd Barbara³,Coghlan J. Gerry⁴,Lordan James⁵,Church Colin⁶,Pepke-Zaba Joanna⁷,Toshner Mark²,Wort Stephen J.¹,Kiely David G.⁸⁹,Condliffe Robin⁸⁹,Lawrie Allan⁸^ORCID,Gräf Stefan²¹⁰^ORCID,Montani David³^ORCID,Boucly Athénaïs³^ORCID,Sitbon Olivier³,Humbert Marc³^ORCID,Howard Luke S.¹,Morrell Nicholas W.²,Wilkins Martin R.¹^ORCID

Affiliation:

1. National Heart and Lung Institute, Imperial College London, London, United Kingdom;

2. Department of Medicine, University of Cambridge, Cambridge, United Kingdom;

3. Université Paris–Saclay, AP-HP, INSERM UMR_S 999, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital de Bicêtre, Le Kremlin Bicêtre, France;

4. Department of Cardiology, Royal Free Campus, University College London, London, United Kingdom;

5. University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom;

6. University of Glasgow, Glasgow, Scotland, United Kingdom;

7. Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, United Kingdom;

8. Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom;

9. Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom; and

10. BioResource for Translational Research, National Institute for Health Research Cambridge Biomedical Campus, Cambridge, United Kingdom

Funder

Medical Research Council

Agence National de la Recherche

British Heart Foundation

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202105-1118OC

Reference47 articles.

1. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

2. Risk stratification and medical therapy of pulmonary arterial hypertension

3. Validation of two predictive models for survival in pulmonary arterial hypertension

4. Predicting Survival in Patients With Pulmonary Arterial Hypertension

5. Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions;JHLT Open;2024-11

2. Role of Artificial Intelligence in Assisting Pulmonary and Critical Care Clinical Decision-Making;American Journal of Respiratory and Critical Care Medicine;2024-09-01

3. Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension;Journal of the American College of Cardiology;2024-09

4. Risk stratification and treatment goals in pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

5. Mechanisms and treatment of pulmonary arterial hypertension;Nature Reviews Cardiology;2024-08-07